Chang Gung Medical Foundation, LinKou Branch
Taoyuan, Taiwan
Hospital in Taoyuan City
No. 5, Fuxing St, Guishan District, Taoyuan City, 333
About Chang Gung Medical Foundation, LinKou Branch
The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
13
Hoffmann-La Roche
9
Eli Lilly and Company
6
Celgene
3
Gilead Sciences
3
Orient Pharma Co., Ltd.
3
Eisai Inc.
2
Merck Sharp & Dohme LLC
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
Allergan
1
Amgen
1
Clinical Trials at Chang Gung Medical Foundation, LinKou Branch
During the past decade, Chang Gung Medical Foundation, LinKou Branch conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 32 clinical trials were completed, i.e. on
average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 17 clinical trials were completed. i.e. 106.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population
2009-12-01
2015-06-01
Terminated
285
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
2011-01-10
2011-12-28
Terminated
23
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
2010-12-01
2013-12-01
Terminated
181
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
2010-12-06
2016-12-20
Completed
224
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chang Gung Medical Foundation, LinKou Branch" #1 sponsor was "Pfizer" with 13 trials, followed by "Hoffmann-La Roche" with 9 trials
sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences"
with 3 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation, LinKou Branch"
#1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Durect" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Chang Gung Medical Foundation, LinKou Branch
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation, LinKou Branch" are
"Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Attention Deficit Hyperactivity Disorder" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "Chang Gung Medical Foundation, LinKou Branch" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation, LinKou Branch
Most popular intervention types in "Chang Gung Medical Foundation, LinKou Branch" are "Drug" (58 trials), "Other" (8 trials) and "Biological" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (21 trials), "Paclitaxel" (5 trials), "Atezolizumab" (4 trials), "Carboplatin" (4 trials) and "Gemcitabine" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation, LinKou Branch
The vast majority of trials in "Chang Gung Medical Foundation, LinKou Branch" are
56 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Chang Gung Medical Foundation, LinKou Branch
Currently, there are NaN active trials in "Chang Gung Medical Foundation, LinKou Branch".
undefined are not yet recruiting,
13 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Chang Gung Medical Foundation, LinKou Branch,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation, LinKou Branch, 4 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 43 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".